Nasopharyngeal Cancer-Reference-Cited by-同舟云学术

Nasopharyngeal Cancer

Published:2004 Issue: Volume: Page:275-293
ISSN:0927-3042
Container-title:Head and Neck Cancer
language:
Short-container-title:

Author:

Chan Anthony TC,Chan M. D.,Teo Peter ML,Teo M. D.,Johnson Philip J,Johnson M. D.

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/0-306-48060-3_11

Reference43 articles.

1. Ho JHC. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978;4:183–205.

2. Lo KW, Cheung ST, Leung SF, et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 1996;56:2721–5.

3. Chan AS, To KF, Lo KW, et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 2000;60:5365–70.

4. Lo KW, Teo PM, Hui AB, et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000;60:3348–53.

5. Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001;61:3877–81.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tetrandrine inhibits cell migration and invasion in human nasopharyngeal carcinoma NPC‐TW 039 cells through inhibiting MAPK and RhoA signaling pathways;Journal of Food Biochemistry;2020-07-27

2. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo;Cancer Communications;2018-05-03

3. Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma;Medical Oncology;2015-02-22

4. Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma;Annals of Oncology;2013-04

5. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway;Cancer Letters;2010-12